losartan has been researched along with Pulmonary Edema in 8 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effects of losartan on the frequency and phenotype of respiratory dendritic cells (DC) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) mice." | 7.80 | [Effects of losartan on pulmonary dendritic cells in lipopolysaccharide- induced acute lung injury mice]. ( Liu, J; Qiu, H; Yang, Y; Yu, T; Zhang, P, 2014) |
| " Herein, we report two episodes of anuria and acute pulmonary edema associated with losartan treatment in a hypertensive patient with preexisting severe renal artery stenosis in a solitary kidney." | 7.72 | Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney. ( Boz, M; Camsari, A; Kiykim, AA; Ozer, C; Yildiz, A, 2004) |
| "This study was performed to demonstrate an experimental procedure of pulmonary edema induced by angiotensin I (AT I) in rats and to elucidate the mechanism of hemodynamic pulmonary edema." | 7.70 | Pulmonary edema induced by angiotensin I in rats. ( Mineshita, S; Shimakura, K; Wang, LM; Xu, ZH; Yamamoto, T, 1998) |
| "We conducted the present study to propose a rabbit model of pulmonary edema (PE) induced by angiotensin II (AII) and to test the preventive effect of losartan on this form of PE." | 7.69 | Angiotensin II-induced pulmonary edema in a rabbit model. ( Koike, Y; Mineshita, S; Sanaka, M; Shimakura, K; Wang, L; Yamamoto, T, 1997) |
| "To assess the effects of losartan on the frequency and phenotype of respiratory dendritic cells (DC) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) mice." | 3.80 | [Effects of losartan on pulmonary dendritic cells in lipopolysaccharide- induced acute lung injury mice]. ( Liu, J; Qiu, H; Yang, Y; Yu, T; Zhang, P, 2014) |
| " Herein, we report two episodes of anuria and acute pulmonary edema associated with losartan treatment in a hypertensive patient with preexisting severe renal artery stenosis in a solitary kidney." | 3.72 | Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney. ( Boz, M; Camsari, A; Kiykim, AA; Ozer, C; Yildiz, A, 2004) |
| "This study was performed to demonstrate an experimental procedure of pulmonary edema induced by angiotensin I (AT I) in rats and to elucidate the mechanism of hemodynamic pulmonary edema." | 3.70 | Pulmonary edema induced by angiotensin I in rats. ( Mineshita, S; Shimakura, K; Wang, LM; Xu, ZH; Yamamoto, T, 1998) |
| "We conducted the present study to propose a rabbit model of pulmonary edema (PE) induced by angiotensin II (AII) and to test the preventive effect of losartan on this form of PE." | 3.69 | Angiotensin II-induced pulmonary edema in a rabbit model. ( Koike, Y; Mineshita, S; Sanaka, M; Shimakura, K; Wang, L; Yamamoto, T, 1997) |
| "Losartan attenuated lung injury by alleviation of the inflammation and cell apoptosis by inhibition of LOX-1 in LPS-induced lung injury." | 1.42 | Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1. ( Deng, J; Deng, W; Deng, Y; Wang, DX; Zhang, T, 2015) |
| "Pretreatment with Losartan attenuated ventilator-induced lung injury and prevented the increase in total protein, the number of apoptotic cells, W/D ratio, MPO, and neutrophil counts caused by high volume ventilation." | 1.35 | Losartan attenuates ventilator-induced lung injury. ( Feng, D; Li, K; Wang, L; Wu, Q; Yao, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Yokota, T | 1 |
| Koiwa, H | 1 |
| Matsushima, S | 1 |
| Tsujinaga, S | 1 |
| Naya, M | 1 |
| Morisaki, H | 1 |
| Morisaki, T | 1 |
| Liu, J | 1 |
| Zhang, P | 1 |
| Yu, T | 1 |
| Yang, Y | 1 |
| Qiu, H | 1 |
| Deng, W | 1 |
| Deng, Y | 1 |
| Deng, J | 1 |
| Wang, DX | 1 |
| Zhang, T | 1 |
| Kiykim, AA | 1 |
| Boz, M | 1 |
| Ozer, C | 1 |
| Camsari, A | 1 |
| Yildiz, A | 1 |
| Yao, S | 1 |
| Feng, D | 1 |
| Wu, Q | 1 |
| Li, K | 1 |
| Wang, L | 2 |
| Yamamoto, T | 2 |
| Shimakura, K | 2 |
| Sanaka, M | 1 |
| Koike, Y | 1 |
| Mineshita, S | 2 |
| Xu, ZH | 1 |
| Wang, LM | 1 |
| Little, WC | 1 |
1 review available for losartan and Pulmonary Edema
| Article | Year |
|---|---|
Hypertensive pulmonary oedema is due to diastolic dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Diastole; Echocardiography, Doppler; Heart Fa | 2001 |
7 other studies available for losartan and Pulmonary Edema
| Article | Year |
|---|---|
Loeys-Dietz Cardiomyopathy? Long-term Follow-up After Onset of Acute Decompensated Heart Failure.
Topics: Acute Disease; Bisoprolol; Cardiomegaly; Cardiomyopathies; Cardiovascular Agents; Echocardiography; | 2022 |
[Effects of losartan on pulmonary dendritic cells in lipopolysaccharide- induced acute lung injury mice].
Topics: Acute Lung Injury; Animals; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Interleukin-6; Lipop | 2014 |
Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Apoptosis; Bronchoalveol | 2015 |
Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney.
Topics: Adult; Antihypertensive Agents; Anuria; Female; Humans; Hypertension, Renovascular; Losartan; Pulmon | 2004 |
Losartan attenuates ventilator-induced lung injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Bronchoalveolar Lavage | 2008 |
Angiotensin II-induced pulmonary edema in a rabbit model.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response | 1997 |
Pulmonary edema induced by angiotensin I in rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti | 1998 |